A citation-based method for searching scientific literature

Xing Yi Woo, Jessica Giordano, Anuj Srivastava, Zi-Ming Zhao, Michael W Lloyd, Roebi de Bruijn, Yun-Suhk Suh, Rajesh Patidar, Li Chen, Sandra Scherer, Matthew H Bailey, Chieh-Hsiang Yang, Emilio Cortes-Sanchez, Yuanxin Xi, Jing Wang, Jayamanna Wickramasinghe, Andrew V Kossenkov, Vito W Rebecca, Hua Sun, R Jay Mashl, Sherri R Davies, Ryan Jeon, Christian Frech, Jelena Randjelovic, Jacqueline Rosains, Francesco Galimi, Andrea Bertotti, Adam Lafferty, Alice C O'Farrell, Elodie Modave, Diether Lambrechts, Petra Ter Brugge, Violeta Serra, Elisabetta Marangoni, Rania El Botty, Hyunsoo Kim, Jong-Il Kim, Han-Kwang Yang, Charles Lee, Dennis A Dean, Brandi Davis-Dusenbery, Yvonne A Evrard, James H Doroshow, Alana L Welm, Bryan E Welm, Michael T Lewis, Bingliang Fang, Jack A Roth, Funda Meric-Bernstam, Meenhard Herlyn, Michael A Davies, Li Ding, Shunqiang Li, Ramaswamy Govindan, Claudio Isella, Jeffrey A Moscow, Livio Trusolino, Annette T Byrne, Jos Jonkers, Carol J Bult, Enzo Medico, Jeffrey H Chuang. Nat Genet 2021
Times Cited: 14







List of co-cited articles
120 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Patient-derived xenografts undergo mouse-specific tumor evolution.
Uri Ben-David, Gavin Ha, Yuen-Yi Tseng, Noah F Greenwald, Coyin Oh, Juliann Shih, James M McFarland, Bang Wong, Jesse S Boehm, Rameen Beroukhim,[...]. Nat Genet 2017
301
57

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
Hui Gao, Joshua M Korn, Stéphane Ferretti, John E Monahan, Youzhen Wang, Mallika Singh, Chao Zhang, Christian Schnell, Guizhi Yang, Yun Zhang,[...]. Nat Med 2015
573
50

Interrogating open issues in cancer precision medicine with patient-derived xenografts.
Annette T Byrne, Denis G Alférez, Frédéric Amant, Daniela Annibali, Joaquín Arribas, Andrew V Biankin, Alejandra Bruna, Eva Budinská, Carlos Caldas, David K Chang,[...]. Nat Rev Cancer 2017
301
42

Prospective derivation of a living organoid biobank of colorectal cancer patients.
Marc van de Wetering, Hayley E Francies, Joshua M Francis, Gergana Bounova, Francesco Iorio, Apollo Pronk, Winan van Houdt, Joost van Gorp, Amaro Taylor-Weiner, Lennart Kester,[...]. Cell 2015
946
35

A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds.
Alejandra Bruna, Oscar M Rueda, Wendy Greenwood, Ankita Sati Batra, Maurizio Callari, Rajbir Nath Batra, Katherine Pogrebniak, Jose Sandoval, John W Cassidy, Ana Tufegdzic-Vidakovic,[...]. Cell 2016
203
35

PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models.
Terrence F Meehan, Nathalie Conte, Theodore Goldstein, Giorgio Inghirami, Mark A Murakami, Sebastian Brabetz, Zhiping Gu, Jeffrey A Wiser, Patrick Dunn, Dale A Begley,[...]. Cancer Res 2017
50
35

Patient-derived xenograft models: an emerging platform for translational cancer research.
Manuel Hidalgo, Frederic Amant, Andrew V Biankin, Eva Budinská, Annette T Byrne, Carlos Caldas, Robert B Clarke, Steven de Jong, Jos Jonkers, Gunhild Mari Mælandsmo,[...]. Cancer Discov 2014
784
35

Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.
Peter Eirew, Adi Steif, Jaswinder Khattra, Gavin Ha, Damian Yap, Hossein Farahani, Karen Gelmon, Stephen Chia, Colin Mar, Adrian Wan,[...]. Nature 2015
386
28

Organoid Modeling of the Tumor Immune Microenvironment.
James T Neal, Xingnan Li, Junjie Zhu, Valeria Giangarra, Caitlin L Grzeskowiak, Jihang Ju, Iris H Liu, Shin-Heng Chiou, Ameen A Salahudeen, Amber R Smith,[...]. Cell 2018
329
28

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.
Andrea Bertotti, Giorgia Migliardi, Francesco Galimi, Francesco Sassi, Davide Torti, Claudio Isella, Davide Corà, Federica Di Nicolantonio, Michela Buscarino, Consalvo Petti,[...]. Cancer Discov 2011
546
28

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.
Krijn K Dijkstra, Chiara M Cattaneo, Fleur Weeber, Myriam Chalabi, Joris van de Haar, Lorenzo F Fanchi, Maarten Slagter, Daphne L van der Velden, Sovann Kaing, Sander Kelderman,[...]. Cell 2018
248
28

Intra-tumour diversification in colorectal cancer at the single-cell level.
Sophie F Roerink, Nobuo Sasaki, Henry Lee-Six, Matthew D Young, Ludmil B Alexandrov, Sam Behjati, Thomas J Mitchell, Sebastian Grossmann, Howard Lightfoot, David A Egan,[...]. Nature 2018
208
28

Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer.
Ryan B Corcoran, Chloe E Atreya, Gerald S Falchook, Eunice L Kwak, David P Ryan, Johanna C Bendell, Omid Hamid, Wells A Messersmith, Adil Daud, Razelle Kurzrock,[...]. J Clin Oncol 2015
265
28

Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.
Sylvia Julien, Ana Merino-Trigo, Ludovic Lacroix, Marc Pocard, Diane Goéré, Pascale Mariani, Sophie Landron, Ludovic Bigot, Fariba Nemati, Peggy Dartigues,[...]. Clin Cancer Res 2012
227
28

Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery.
Ian R Powley, Meeta Patel, Gareth Miles, Howard Pringle, Lynne Howells, Anne Thomas, Catherine Kettleborough, Justin Bryans, Tim Hammonds, Marion MacFarlane,[...]. Br J Cancer 2020
29
21

Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish.
Chuan Yan, Dalton C Brunson, Qin Tang, Daniel Do, Nicolae A Iftimia, John C Moore, Madeline N Hayes, Alessandra M Welker, Elaine G Garcia, Taronish D Dubash,[...]. Cell 2019
74
21

Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts.
Kristel Kemper, Oscar Krijgsman, Paulien Cornelissen-Steijger, Aida Shahrabi, Fleur Weeber, Ji-Ying Song, Thomas Kuilman, Daniel J Vis, Lodewyk F Wessels, Emile E Voest,[...]. EMBO Mol Med 2015
81
21

Mouse hospital and co-clinical trial project--from bench to bedside.
John G Clohessy, Pier Paolo Pandolfi. Nat Rev Clin Oncol 2015
63
21


Organoids in cancer research.
Jarno Drost, Hans Clevers. Nat Rev Cancer 2018
399
21

Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids.
Ana C F Bolhaqueiro, Bas Ponsioen, Bjorn Bakker, Sjoerd J Klaasen, Emre Kucukkose, Richard H van Jaarsveld, Judith Vivié, Ingrid Verlaan-Klink, Nizar Hami, Diana C J Spierings,[...]. Nat Genet 2019
61
21

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.
Andrea Sartore-Bianchi, Livio Trusolino, Cosimo Martino, Katia Bencardino, Sara Lonardi, Francesca Bergamo, Vittorina Zagonel, Francesco Leone, Ilaria Depetris, Erika Martinelli,[...]. Lancet Oncol 2016
411
21

EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer.
Vito Amodio, Rona Yaeger, Pamela Arcella, Carlotta Cancelliere, Simona Lamba, Annalisa Lorenzato, Sabrina Arena, Monica Montone, Benedetta Mussolin, Yu Bian,[...]. Cancer Discov 2020
45
21

The genomic landscape of response to EGFR blockade in colorectal cancer.
Andrea Bertotti, Eniko Papp, Siân Jones, Vilmos Adleff, Valsamo Anagnostou, Barbara Lupo, Mark Sausen, Jillian Phallen, Carolyn A Hruban, Collin Tokheim,[...]. Nature 2015
252
21

Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer.
Claudio Isella, Francesco Brundu, Sara E Bellomo, Francesco Galimi, Eugenia Zanella, Roberta Porporato, Consalvo Petti, Alessandro Fiori, Francesca Orzan, Rebecca Senetta,[...]. Nat Commun 2017
109
21

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.
Georgios Vlachogiannis, Somaieh Hedayat, Alexandra Vatsiou, Yann Jamin, Javier Fernández-Mateos, Khurum Khan, Andrea Lampis, Katherine Eason, Ian Huntingford, Rosemary Burke,[...]. Science 2018
498
21

A rectal cancer organoid platform to study individual responses to chemoradiation.
Karuna Ganesh, Chao Wu, Kevin P O'Rourke, Bryan C Szeglin, Youyun Zheng, Charles-Etienne Gabriel Sauvé, Mohammad Adileh, Isaac Wasserman, Michael R Marco, Amanda S Kim,[...]. Nat Med 2019
82
21

Immunogenomics of Colorectal Tumors: Facts and Hypotheses on an Evolving Saga.
Irene Catalano, Elena Grassi, Andrea Bertotti, Livio Trusolino. Trends Cancer 2019
10
30

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.
Funda Meric-Bernstam, Herbert Hurwitz, Kanwal Pratap Singh Raghav, Robert R McWilliams, Marwan Fakih, Ari VanderWalde, Charles Swanton, Razelle Kurzrock, Howard Burris, Christopher Sweeney,[...]. Lancet Oncol 2019
114
21

Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer.
Ye Yao, Xiaoya Xu, Lifeng Yang, Ji Zhu, Juefeng Wan, Lijun Shen, Fan Xia, Guoxiang Fu, Yun Deng, Mengxue Pan,[...]. Cell Stem Cell 2020
98
21

Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases.
Fleur Weeber, Marc van de Wetering, Marlous Hoogstraat, Krijn K Dijkstra, Oscar Krijgsman, Thomas Kuilman, Christa G M Gadellaa-van Hooijdonk, Daphne L van der Velden, Daniel S Peeper, Edwin P J G Cuppen,[...]. Proc Natl Acad Sci U S A 2015
193
21

Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients.
Salo N Ooft, Fleur Weeber, Krijn K Dijkstra, Chelsea M McLean, Sovann Kaing, Erik van Werkhoven, Luuk Schipper, Louisa Hoes, Daniel J Vis, Joris van de Haar,[...]. Sci Transl Med 2019
124
21

HER2 activating mutations are targets for colorectal cancer treatment.
Shyam M Kavuri, Naveen Jain, Francesco Galimi, Francesca Cottino, Simonetta M Leto, Giorgia Migliardi, Adam C Searleman, Wei Shen, John Monsey, Livio Trusolino,[...]. Cancer Discov 2015
147
21

A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis.
Masayuki Fujii, Mariko Shimokawa, Shoichi Date, Ai Takano, Mami Matano, Kosaku Nanki, Yuki Ohta, Kohta Toshimitsu, Yoshihiro Nakazato, Kenta Kawasaki,[...]. Cell Stem Cell 2016
302
21

Chimeric Antigen Receptor-modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model.
Ruidi Teng, Jingjing Zhao, Yiding Zhao, Junshuang Gao, Haibo Li, Shixin Zhou, Yuan Wang, Qiang Sun, Zhongqing Lin, Weifeng Yang,[...]. J Immunother 2019
17
21

Cryopreservation of human colorectal carcinomas prior to xenografting.
Michael Linnebacher, Claudia Maletzki, Christiane Ostwald, Ulrike Klier, Mathias Krohn, Ernst Klar, Friedrich Prall. BMC Cancer 2010
52
21

Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening.
Carla S Verissimo, René M Overmeer, Bas Ponsioen, Jarno Drost, Sander Mertens, Ingrid Verlaan-Klink, Bastiaan van Gerwen, Marieke van der Ven, Marc van de Wetering, David A Egan,[...]. Elife 2016
109
21

Xenograft and organoid model systems in cancer research.
Margit Bleijs, Marc van de Wetering, Hans Clevers, Jarno Drost. EMBO J 2019
73
21

Preclinical mouse cancer models: a maze of opportunities and challenges.
Chi-Ping Day, Glenn Merlino, Terry Van Dyke. Cell 2015
270
14

The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research.
Nathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, Sabina Alam, Marc T Avey, Monya Baker, William J Browne, Alejandra Clark, Innes C Cuthill, Ulrich Dirnagl,[...]. PLoS Biol 2020
350
14

Cancer modeling meets human organoid technology.
David Tuveson, Hans Clevers. Science 2019
173
14

DHODH modulates transcriptional elongation in the neural crest and melanoma.
Richard Mark White, Jennifer Cech, Sutheera Ratanasirintrawoot, Charles Y Lin, Peter B Rahl, Christopher J Burke, Erin Langdon, Matthew L Tomlinson, Jack Mosher, Charles Kaufman,[...]. Nature 2011
286
14

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma.
Clemens Krepler, Katrin Sproesser, Patricia Brafford, Marilda Beqiri, Bradley Garman, Min Xiao, Batool Shannan, Andrea Watters, Michela Perego, Gao Zhang,[...]. Cell Rep 2017
63
14

Locally Aggressive Connective Tissue Tumors.
Mrinal M Gounder, David M Thomas, William D Tap. J Clin Oncol 2018
22
14



Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors.
Gennadiy Bondarenko, Andrey Ugolkov, Stephen Rohan, Piotr Kulesza, Oleksii Dubrovskyi, Demirkan Gursel, Jeremy Mathews, Thomas V O'Halloran, Jian J Wei, Andrew P Mazar. Neoplasia 2015
53
14


Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance.
Jean-Pierre Gillet, Anna Maria Calcagno, Sudhir Varma, Miguel Marino, Lisa J Green, Meena I Vora, Chirayu Patel, Josiah N Orina, Tatiana A Eliseeva, Vineet Singal,[...]. Proc Natl Acad Sci U S A 2011
266
14

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
Norman Sachs, Joep de Ligt, Oded Kopper, Ewa Gogola, Gergana Bounova, Fleur Weeber, Anjali Vanita Balgobind, Karin Wind, Ana Gracanin, Harry Begthel,[...]. Cell 2018
456
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.